Profile details
About Joshua Samuel
Josh is an associate focusing on the representation of life sciences companies on corporate, transactional, and commercial matters.
Recent work
- Moderna on a strategic collaboration and license of CytomX's Probody technology for use with Moderna's mRNA therapeutics, including a $35 million upfront cash payment and up to $1.2 billion in milestones.
- Alexion, AstraZeneca Rare Disease on its acquisition of LogicBio® Therapeutics, Inc.
Qualifications
Education
- Columbia Law School
- J.D., 2021
- Texas A&M University
- B.A., summa cum laude, 2018
Bar Admission
- Admitted to the New York State Bar